$159.99
GLP-2 T is supplied in capsule form for research involving peptide structure, receptor interaction, and formulation analysis. Each bottle contains 60 capsules at 1 mg per capsule. This compound is intended strictly for laboratory research use only and is not for human or veterinary use.
PubChem identifies tirzepatide as a long-chain peptide analogue with a defined molecular formula and structural modifications that differentiate it from native incretin peptides. The compound incorporates a C20 fatty diacid moiety linked via a spacer to the peptide backbone, which is commonly analyzed in research focused on peptide conjugation, lipidation strategies, and molecular stability. [1]
Such structural features make tirzepatide relevant in laboratory studies examining peptide folding, steric interactions, and the impact of chemical modifications on physicochemical properties. These investigations are typically conducted under controlled in vitro or analytical conditions to characterize peptide behavior and degradation profiles. [1][2]
Tirzepatide is indexed in PubChem in association with both GIP receptor (GIPR) and GLP-1 receptor (GLP1R) targets, making it relevant for research involving dual receptor engagement and ligand-receptor binding dynamics. [2]
This dual-target profile allows for experimental work comparing receptor selectivity, binding affinity, and signaling pathway activation across incretin receptor families. Researchers may utilize tirzepatide in assays designed to study receptor co-activation, competitive binding models, and downstream signaling cascades within controlled laboratory environments. [2]
The presence of a lipidated side chain in tirzepatide supports ongoing research into peptide formulation strategies, including stability enhancement, aggregation resistance, and interaction with delivery matrices. PubChem records and associated literature references highlight its relevance in comparative studies between native peptides and structurally modified analogues. [1][3]
In capsule format, GLP-2 T may be utilized in non-clinical research settings focused on dosage-form analysis, excipient compatibility, and stability testing under varied storage conditions. These applications are strictly investigational and intended for qualified laboratory use only. [1]
This product is supplied as 1 mg capsules, 60 capsules per bottle, and is designated strictly as a research chemical. It is not intended for human consumption, veterinary use, or therapeutic application.
GLP-2 T is a synthetic peptide listed in PubChem and classified as a dual agonist targeting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is a modified linear peptide composed of amino acid substitutions and a lipidated side chain, designed for enhanced stability and receptor interaction in controlled experimental systems. [1][2]
This product is meant only for research use. It is made for lab testing and in vitro experiments (outside a living body), not for use in people or animals. All information on this website is for learning purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. It should only be used by trained professionals in a proper lab setting. This product is not a medicine, food, or cosmetic, and must not be sold or used as one.
